DK0757556T3 - Borrelia Burgdorferi-bakterin - Google Patents

Borrelia Burgdorferi-bakterin

Info

Publication number
DK0757556T3
DK0757556T3 DK95916950T DK95916950T DK0757556T3 DK 0757556 T3 DK0757556 T3 DK 0757556T3 DK 95916950 T DK95916950 T DK 95916950T DK 95916950 T DK95916950 T DK 95916950T DK 0757556 T3 DK0757556 T3 DK 0757556T3
Authority
DK
Denmark
Prior art keywords
borrelia burgdorferi
bacterin
crossprotective
antigenic
isolates
Prior art date
Application number
DK95916950T
Other languages
English (en)
Inventor
Jon B Korshus
Paul L Runnels
Richard L Sharpee
Ronald F Schell
Steven M Callister
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of DK0757556T3 publication Critical patent/DK0757556T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/828—Bacterial vaccine for canidae or mustelidae, e.g. dogs, foxes, minks

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Cephalosporin Compounds (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
DK95916950T 1994-04-11 1995-04-11 Borrelia Burgdorferi-bakterin DK0757556T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US22629794A 1994-04-11 1994-04-11

Publications (1)

Publication Number Publication Date
DK0757556T3 true DK0757556T3 (da) 2006-10-02

Family

ID=22848351

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95916950T DK0757556T3 (da) 1994-04-11 1995-04-11 Borrelia Burgdorferi-bakterin

Country Status (9)

Country Link
US (5) US6316005B1 (da)
EP (1) EP0757556B1 (da)
AT (1) ATE329615T1 (da)
CA (1) CA2187535C (da)
DE (1) DE69535059T2 (da)
DK (1) DK0757556T3 (da)
ES (1) ES2265643T3 (da)
PT (1) PT757556E (da)
WO (1) WO1995027504A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2265643T3 (es) * 1994-04-11 2007-02-16 Wyeth Holdings Corporation Bacteria de borrelia burgdorferi.
BRPI0719360B1 (pt) 2006-11-03 2016-09-06 Intervet Int Bv vacina da doença de lyme canina, e, uso de organismos de uma genoespécie de borrelia
CZ301244B6 (cs) * 2007-11-14 2009-12-16 Bioveta, A.S. Univerzální vakcína k lécbe a prevenci Lymeské borreliózy pro humánní a veterinární použití a zpusob její výroby
CZ301548B6 (cs) * 2008-08-20 2010-04-14 Bittner@Libor Univerzální preparát ke zvýšení obranyschopnosti, prevenci, profylaxi a lécbe Lymeské boreliózy pro humánní a veterinární použití, zpusob jeho výroby a použití
CN103229055A (zh) * 2010-09-27 2013-07-31 康奈尔大学 莱姆病的诊断方法
WO2013049039A1 (en) 2011-09-30 2013-04-04 Advanced Laboratory Services, Inc. Compositions and methods for culturing spirochetes
US9128584B2 (en) * 2013-02-15 2015-09-08 Carl Zeiss X-ray Microscopy, Inc. Multi energy X-ray microscope data acquisition and image reconstruction system and method
CA3082959A1 (en) 2017-12-04 2019-06-13 Intervet International B.V. Canine lyme disease vaccine

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK590288D0 (da) 1988-10-24 1988-10-24 Symbicom Ab Kemiske forbindelser
US4002736A (en) * 1974-12-16 1977-01-11 Pankratz Duane C Porcine bacterin
US4171354A (en) * 1977-06-23 1979-10-16 Ohio Agricultural Research And Development Center Vaccine for animal respiratory diseases
US4223014A (en) * 1978-05-08 1980-09-16 The United States Of America As Represented By The Secretary Of The Interior Spray immunization of fish
US4423035A (en) * 1981-08-10 1983-12-27 Schering Corporation Method for preventing injection site abscess
US4746613A (en) * 1984-03-02 1988-05-24 Wichmann Robert W Poultry diseases bacterin preparation
US4721617A (en) * 1986-08-14 1988-01-26 Regents Of The University Of Minnesota Vaccine against lyme disease
US4818528A (en) * 1987-02-06 1989-04-04 The University Of Tennessee Research Corporation Vaccine against infectious bovine keratoconjunctivitis
US5248501A (en) * 1988-11-22 1993-09-28 Parnell Pharmaceuticals Drug delivery systems containing eriodictyon fluid extract as an excipient, and methods and compositions associated therewith
CA2011896C (en) * 1989-04-21 2001-05-08 Mark Werner Ringworm vaccine
US5385826A (en) * 1989-04-21 1995-01-31 Gundersen Medical Foundation, Ltd. Diagnostic assay for lyme disease
US5582829A (en) * 1990-04-05 1996-12-10 Rx Technologies, Inc. Sonicated borrelia burgdorferi vaccine
SG47447A1 (en) * 1990-06-15 1998-04-17 Univ Yale Compositions and methods for the prevention and diagnosis of lyme disease
EP1016416A3 (en) * 1990-07-06 2002-10-23 Wyeth Vaccine against lyme disease and a challenge model for evaluating vaccine efficacy
US6221363B1 (en) 1991-07-11 2001-04-24 Baxter Aktiengesellschaft Vaccine for the prevention of lyme disease
DE69229476T2 (de) * 1991-08-15 2000-03-16 Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts Ospa proteine von borrelia burgdorferi untergruppen, dafür kodierende gene sowie impfstoffe
ATE234365T1 (de) * 1991-10-22 2003-03-15 Symbicom Ab Verbesserungen der diagnose und der prophylaxe von borrelia burgdorferi
EP0659086B1 (en) * 1992-09-04 1998-11-11 The University of Saskatchewan Novel bacterial vaccines using vaccine strains of pathogenic bacteria
US5656451A (en) * 1993-07-30 1997-08-12 Yale University OspE, OspF, and S1 polypeptides in borrelia burgdorferi
US6303130B1 (en) * 1993-11-02 2001-10-16 The United States Of America As Represented By The Secretary Of Agriculture Pasteurella haemolytica vaccine inactivated by ultraviolet light
ES2265643T3 (es) * 1994-04-11 2007-02-16 Wyeth Holdings Corporation Bacteria de borrelia burgdorferi.
US6673346B1 (en) * 1999-08-31 2004-01-06 The Regents Of The University Of Michigan Compositions and methods for the treatment of sepsis
US7018638B2 (en) * 2000-12-19 2006-03-28 Wyeth Mycoplasma hyopneumoniae bacterin vaccine
US7429388B2 (en) * 2004-04-01 2008-09-30 The Research Foundation Of State University Of New York Vaccine for nontypeable Haemophilus influenzae infection
BRPI0719360B1 (pt) * 2006-11-03 2016-09-06 Intervet Int Bv vacina da doença de lyme canina, e, uso de organismos de uma genoespécie de borrelia

Also Published As

Publication number Publication date
DE69535059D1 (en) 2006-07-27
DE69535059T2 (de) 2007-01-18
US20020071851A1 (en) 2002-06-13
ATE329615T1 (de) 2006-07-15
CA2187535C (en) 2011-09-13
US6316005B1 (en) 2001-11-13
EP0757556B1 (en) 2006-06-14
ES2265643T3 (es) 2007-02-16
US20050042235A1 (en) 2005-02-24
US20080026009A1 (en) 2008-01-31
EP0757556A4 (en) 1997-08-27
CA2187535A1 (en) 1995-10-19
EP0757556A1 (en) 1997-02-12
PT757556E (pt) 2006-10-31
WO1995027504A1 (en) 1995-10-19
US20110256178A1 (en) 2011-10-20

Similar Documents

Publication Publication Date Title
GB2322801B (en) Vaccine compositions for intranasal administration comprising chitosan and use thereof
CA2089552A1 (en) Inactivated mycoplasma hyopneumoniae bacterin and method of use thereof
IS4518A (is) Nýtt lyfjaform fyrir bóluefni
ES2140076T3 (es) Vacunas que contienen una saponina y un esterol.
EP1170016A3 (en) Urease-based vaccine against helicobacter infection
HUP0400687A2 (hu) Mycoplasma hyopneumoniae bakterin-vakcina
DK0672116T3 (da) Deletionsmutanter som vacciner mod kolera
NL300186I1 (nl) Acellulair vaccin.
DK0757556T3 (da) Borrelia Burgdorferi-bakterin
PT792165E (pt) Composicoes imunogenicas
HK1004677A1 (en) Antigenic preparation for treatment or prevention of helicobacter infection
WO1997045139A3 (en) Il-12 as an adjuvant for bordetella pertussis vaccines
EP0954529A4 (en) Porphyromonas gingivalis antigen for the diagnosis and treatment of periodontitis
WO1997011669A3 (en) MHC-class II restricted melanoma antigens and their use in therapeutic methods
FI971402A0 (fi) Menetelmä voimistettujen antigeenisten Helico-bacter-lajien ja niitä sisältävien rokotteiden valmistamiseksi
SE9604322D0 (sv) Bacterial antigens and vaccine compositions II
AU4537100A (en) Adjuvant combinations for immunization composition and vaccines
ECSP961731A (es) Vacunas